Exploring gene silencing mechanisms for improved RNAi therapeutics

RNA interference (RNAi) therapeutics have garnered significant attention in clinical research due to their potential for treating various diseases, including genetic disorders, viral infections and cancer.


http://dlvr.it/TC9WTx

Comments

Post a Comment

Popular posts from this blog

GLP-1 Drugs Before Bariatric Surgery Can Help People With Extreme Obesity

Image
A new study looked at the impact of taking GLP-1 drugs before bariatric surgery. Halfpoint/Getty Images * New research finds that using GLP-1 drugs like Ozempic before bariatric surgery can help improve the health of people with extreme obesity. * Extreme obesity is defined as having a body mass index (BMI) of 70 or more. * In 2022, there were nearly 280,000 metabolic and bariatric surgeries in the United States. People with extreme obesity can reduce their risk of complications from bariatric or metabolic surgery by taking GLP-1 drugs before the procedures, according to a study presented over the weekend at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting. The results of the study haven’t yet been published in a peer-reviewed scientific journal. Extreme obesity, which is defined as having a body mass index (BMI) of 70 or more, presents patients and doctors with complications during and after weight-loss surgery c...
Read more

Women Will Be Notified Of Breast Density After a Mammogram: What to Know

Image
The FDA will now require all mammography reports to include whether a person has breast density, which is a breast cancer risk factor. Johnny Greig/Getty Images * The FDA will now require all mammography reports to include whether a person has breast density. * Breast density is considered a risk factor for breast cancer and can make it difficult to detect signs of cancer. * Dietary and lifestyle modifications may help reduce breast density, but more importantly, they help lower a person’s risk of developing breast cancer. Mammograms are the gold standard for breast cancer detection starting around age 40.  Breast density can raise breast cancer risk and make it more difficult to detect cancer. Still, many people are unaware of this important risk factor, even if they regularly receive mammograms. On September 10, the Food and Drug Administration (FDA) issued a final rule that will require breast density to be included in mammography reports. This amendmen...
Read more